This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International
September 22-25, 2026
Hynes Convention CenterBoston, USA
Menu
Key Sessions
Fouad Atouf
PLENARY KEYNOTE: Evolving Pharmacopeial Standards to Shape the Future of Biological Medicines
US Pharmacopeia
Amy Shaw
Scale-Out Versus Scale-Up Strategies for Maximizing Cellular Therapies
Takeda, USA
Kelvin Lee
KEYNOTE: The Future of Biopharmaceutical Manufacturing: Innovation and Collaboration
NIIMBL
keyboard_arrow_right

Wednesday 17th September - Main Conference Day Two - ET (Eastern Time, GMT-05:00)

keyboard_arrow_leftSearch & Filter
search
Wednesday 17th September - Main Conference Day Two - ET (Eastern Time, GMT-05:00)
search
Showing 1 of 1 Streams
11:25am - 11:30am
Chairperson Remarks: Analytical, Quality and Characterization
  • Hemant Kumar - Founder, F2 BioSolutions
11:30am - 12:00pm
Ensuring Product Comparability & Accelerating Analytical Method Development: Bridging Early and Late-Phase Development
  • Elisabeth Krug - Executive Director, BRD Analytical Development, Eli Lilly & Company
12:00pm - 12:30pm
Overcoming the Barriers to Further Adoption of MAM
  • Hao Zhang - Sr. Principal Scientist, Amgen
12:30pm - 1:00pm
Application of Raman Spectroscopy to Monitor Product Quality in Purification Workflows
  • Hadi El Radi - PAT Implementation & Support Engineer, MilliporeSigma
  • Sabrina Yang - Purification Development Scientist, CSL Innovation Pty Ltd
Showing 1 of 1 Streams
2:10pm - 2:15pm
Chairperson Remarks: Analytical, Quality and Characterization
  • Kevin Zen, PhD - CMC Technical Operations, Opthea
2:15pm - 2:45pm
Innovative Approaches to Potency & Stability: Overcoming Analytical Drug-Delivery Challenges
  • Arvind Srivastava, Ph.D. - Senior Vice President, ThirdArcBio
2:45pm - 3:15pm
Emerging Technologies & Bioassay Innovations: Bridging the Gap Between Development and Compliance
  • Anand Srinivasan - Vice President of Technology and Innovations, and Head of the Center for Innovations and Biodesign, BioBridge Global
3:15pm - 3:45pm
Streamlining residual host cell impurity monitoring in biotherapeutic products: Driving efficiency and precision
  • Anis Khimani, PhD - Senior Strategy Leader, Revvity Inc
Showing 1 of 1 Streams
4:30pm - 5:00pm
Defining and Controlling Critical Quality Attributes (CQAs) for Gene and Cell Therapies
  • Callum Chapman - Senior Director,  Product Quality, AstraZeneca
5:00pm - 5:30pm
AI's Power in the Future of Process Analytical Technology (PAT)
  • William Whitford - Founder, Oamaru BioSystems
Tuesday 16th September - Main Conference Day One
NextThursday 18th September - Main Conference Day Three
Filter
Streams
Clear
Choose Day